Evolution of anti-HIV drug candidates. Part 1: From α-Anilinophenylacetamide (α-APA) to imidoyl thiourea (ITU)
- 1 September 2001
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (17) , 2225-2228
- https://doi.org/10.1016/s0960-894x(01)00410-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Non-nucleoside reverse transcriptase inhibitors in the treatment of human immunodeficiency virus infectionEmerging Drugs, 1997
- Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitorsNature Structural & Molecular Biology, 1995
- HIV Drug ResistanceAnnual Review of Pharmacology and Toxicology, 1993
- Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an InhibitorScience, 1992
- Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture.Proceedings of the National Academy of Sciences, 1991
- Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivativesJournal of Medicinal Chemistry, 1991
- Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivativesNature, 1990
- An efficient conversion of nitriles to amidinesTetrahedron Letters, 1990
- Reactions of (E)-1-Methoxy-1-trimethylsiloxyprop-1-ene with acyl isocyanates and acyl isothiocyanatesAustralian Journal of Chemistry, 1984
- Synthesis of 2‐Pyridyl‐α‐toluenesulfonates as AntimalarialsJournal of Pharmaceutical Sciences, 1975